![]() | ![]() |
Formats:
|
||||||||||
Copyright © 2006 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Midfacial Degloving: The Best Alternative for Treatment of Trans-sphenoidal Meningocele of the Pterygopalatine Fossa 1Center of Otorhinolaryngology, Head & Neck and Skull Base Surgery, Euroclinic Athens, Athens, Greece Address for correspondence and reprint requests: Nikolaos Marangos M.D. Euroclinic Athens, 9 Athanasiadou St., 115 21, Athens, Greece, Email: orlmar/at/otenet.gr This article has been cited by other articles in PMC.ABSTRACT Trans-sphenoid anterobasal temporal lobe meningoceles are rare and can be associated with temporal lobe epilepsy or recurrent meningitis. Surgical treatment is described via complicated infratemporal or intracranial approaches with high morbidity. A 32-year-old man presented with an 18-year history of two types of seizures and confirmed epileptic activity in electroencephalogram. A trans-sphenoid meningocele in the left pterygopalatine fossa was found on computed tomography and magnetic resonance imaging. A midfacial degloving was chosen instead of a large neurosurgical approach to remove it and to repair the dura defect with lyophilized dura, collagen, and abdominal fat. The postoperative course was uneventful without visible scars and the patient remains free of seizures without antiepileptic medication 3 years after surgery. Although midfacial degloving is not described yet as a treatment of trans-sphenoid meningoceles, this approach proved to be fast, safe, effective, and reliable and should be considered as the only alternative to large external approaches. Keywords: Midfacial degloving, trans-sphenoid meningocele, pterygopalatine fossa Structural anomalies of the central nervous system such as congenital or post-traumatic meningocerebral cicatrix, mesial temporal sclerosis, hamartomas, and indolent neoplasms are frequently associated with epilepsy.1 Congenital meningoencephaloceles of the skull base are commonly classified according to the site of the bone defect2,3,4 and can also result in epileptic disease. Pollock classifies them as follows: (1) sphenopharyngeal or trans-sphenoidal, when they protrude into the epipharynx and/or sphenoid sinus; (2) spheno-orbital, when the protrusion is through the superior orbital fissure into the superior orbit producing unilateral exophthalmus; (3) sphenoethmoidal, when the cerebral mass extends through the sphenoid and ethmoidal bones into the posterior nasal cavity; (4) transethmoidal, when the encephalocele extends into the anterior nasal cavity; and (5) sphenomaxillary, when the meningoencephalocele passes through the superior orbital fissure into the orbit and through the inferior orbital fissure into the pterygopalatine fossa.2 The trans-sphenoidal meningo(encephalo)celes are congenital caused by incomplete embryogenesis of the Ala sphenoidalis major thus protruding in the pterygopalatine fossa.5 They are extremely rare among the meningo(encephalo)celes of the skull base. Their cardinal symptom is temporal lobe epilepsy. The extension of gliosis from the encephalocele in direct continuity to the amygdalohippocampal region, the most active epileptic area, is considered as the pathomechanism of epilepsy.5 Occasionally, this lesion can be discovered during evaluation for recurrent meningitis.6 Computed tomography (CT) usually demonstrates the bony gap and magnetic resonance imaging (MRI) reveals the extent of soft tissue prolapse and allows differentiation between cerebrospinal fluid (CSF) and tissue. Further, MRI detects cases that cannot be diagnosed by CT, which is obligatory in evaluating epilepsy.7 Surgical approach to the middle skull base and pterygopalatine fossa for any kind of benign and malignant processes is a challenge for both neurosurgeons and maxillofacial surgeons and results in sophisticated procedures, such as infratemporal approach, or after anterior subtemporal craniotomy or temporary sagittal mandibulotomy.8,9,10,11,12,13 We report a case of trans-sphenoid meningocele in an adult that resulted in a medically resistant temporal lobe epilepsy. Although not described in the literature, the midfacial degloving was chosen for its surgical management. CASE REPORT The subject was a 32-year-old male with a history of two types of seizures for the previous 18 years. The first type began at the age of 14 initially with paresthesias affecting the fingers and feet and dizzy spells lasting several minutes, followed by loss of consciousness and urinary incontinence. The second type, consisting of generalized tonicoclonic seizure (grand mal), first occurred at the age of 27 and continued in 6- to 8-month intervals until presentation. The patient had an intense lifestyle with alcohol and cigarette abuse and was exposed to professional physical strain as well. He reported that seizures usually occurred during infections of the upper respiratory tract while blowing his nose, or after extreme body fatigue. Antiepileptic treatment for the last 2 years failed to prevent them. There was no history of head injury at birth or later. The patient's physical examination was normal. Neurological evaluation including electroencephalogram confirmed a left temporal lobe dysfunction. Epileptic activity was recorded from the mesial and anterior neocortical surfaces. CT of the skull base demonstrated a defect at the left Ala sphenoidalis major and soft tissue protruding into the pterygopalatine fossa as typical trans-sphenoid meningocele (Fig. 1
The periosteum of the canine fossae was elevated, preserving the infraorbital nerves. The skin of the lower third of the nose was cranially dislocated toward the glabella by using a wet gauze (Fig. 2B
The postoperative course was uneventful under antibiotic cover with ceftriaxone (Rocephin®) and the patient was discharged 2 days later. He is free of seizures 3 years after surgery without antiepileptic treatment. DISCUSSION Trans-sphenoidal meningo(encephalo)celes at the region of the foramen rotundum and pterygoid process protruding in the pterygopalatine fossa are obviously very rare, since only five cases could be found in our literature research. Four of them caused epilepsy5,15 and one patient experienced recurrent meningitis.6 None of these, including our case, fit into the classification system of skull base meningoceles according to Pollock,2 since they did not protrude into the pterygopalatine fossa through the orbit as the described sphenomaxillary ones, but through paramedial dehiscence (see Fig. Fig.1C),1C Since these meningo(encephalo)celes protrude in the pterygopalatine fossa, they are not apparent during clinical examination and sometimes even the CT scan fails to reveal them. For that reason, the presence of the meningocele was evident intraoperatively during temporal lobectomy for the treatment of temporal lobe epilepsy.5,15 Thus, this disease should be seriously considered in the differential diagnosis of late-onset temporal lobe epilepsy. MRI is recommended for definitive exclusion or confirmation.7 Because surgical access to the region is very demanding, various approaches have been described. Most of them refer to malignant processes, where functional and esthetic compromises can be tolerated to achieve radical tumor resection.8,9,10,11 However, extended facial scars as well as high risk of facial nerve or other cranial nerve palsies after temporary sagittal mandibulotomy are obsolete for treatment of benign processes like the trans-sphenoid meningocele. Anterior subtemporal craniotomy, which requires severe retraction of the brain to access the region (with high morbidity), seems to be over-treatment as well. Recent minimally invasive endoscopic techniques for benign processes of the nose and paranasal sinus are indicated only for minor surgery in the pterygopalatine fossa.12,13 We strongly advocate the transantral endoscopic midfacial degloving approach as a safe, effective, and reliable surgical approach for the treatment of pterygopalatine fossa meningoceles. It allows sufficient exposure for complete resection of the sac. It provides an unobstructed view and space for manipulation to control complications like bleeding of the internal maxillary artery and CSF leak. The only cranial nerve at risk is the second branch of the trigeminal nerve, which should be identified and routinely preserved. Further, all incisions are invisible so that external scars and cosmetic deformities can definitely be avoided. Thus, midfacial degloving should be considered as the only alternative for the treatment of trans-sphenoid meningo(encephalo)celes. REFERENCES
|
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||
Radiology. 1968 Mar; 90(3):442-53.
[Radiology. 1968]J Neurosurg. 1972 Feb; 36(2):201-11.
[J Neurosurg. 1972]World J Surg. 1989 Jul-Aug; 13(4):349-57.
[World J Surg. 1989]J Neurosurg. 1991 Jun; 74(6):933-9.
[J Neurosurg. 1991]J Neurosurg. 2000 Sep; 93(3):480-3.
[J Neurosurg. 2000]Ann Neurol. 1987 Sep; 22(3):341-7.
[Ann Neurol. 1987]Ann Otol Rhinol Laryngol. 1970 Oct; 79(5):967-9.
[Ann Otol Rhinol Laryngol. 1970]J Laryngol Otol. 1980 Feb; 94(2):149-62.
[J Laryngol Otol. 1980]J Oral Maxillofac Surg. 1986 Mar; 44(3):183-7.
[J Oral Maxillofac Surg. 1986]Am J Rhinol. 2002 Mar-Apr; 16(2):113-8.
[Am J Rhinol. 2002]Arch Otolaryngol Head Neck Surg. 2003 Apr; 129(4):441-6.
[Arch Otolaryngol Head Neck Surg. 2003]HNO. 1990 Jan; 38(1):7-11.
[HNO. 1990]J Neurosurg. 1991 Jun; 74(6):933-9.
[J Neurosurg. 1991]J Neurosurg. 2000 Sep; 93(3):480-3.
[J Neurosurg. 2000]Radiology. 1968 Mar; 90(3):442-53.
[Radiology. 1968]J Neurosurg. 1991 Jun; 74(6):933-9.
[J Neurosurg. 1991]Ann Neurol. 1987 Sep; 22(3):341-7.
[Ann Neurol. 1987]Ann Otol Rhinol Laryngol. 1970 Oct; 79(5):967-9.
[Ann Otol Rhinol Laryngol. 1970]J Laryngol Otol. 1980 Feb; 94(2):149-62.
[J Laryngol Otol. 1980]J Oral Maxillofac Surg. 1986 Mar; 44(3):183-7.
[J Oral Maxillofac Surg. 1986]Am J Rhinol. 2002 Mar-Apr; 16(2):113-8.
[Am J Rhinol. 2002]Arch Otolaryngol Head Neck Surg. 2003 Apr; 129(4):441-6.
[Arch Otolaryngol Head Neck Surg. 2003]